Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy

Clinica Chimica Acta

Volumn 412, Issue 15-16, 2011, Pages 1407-1411

  De Carvalho, José A M ^a,b   Piva, Sílvia J ^a   Hausen, Bruna S ^a   Bochi, Guilherme V ^a   Kaefer, Michelle ^b   Coelho, Adriane C ^b,c   Duarte, Marta M M F ^d   Moresco, Rafael N ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Hospital Universitario de Santa Maria   (Brazil)

^c Associação dos Diabéticos e Hipertensos   (Brazil)

^d UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

glutamyltransferase; Albuminuria; Alkaline phosphatase; Diabetic nephropathy

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CREATININE; FRUCTOSAMINE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ANALYSIS; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; URIC ACID BLOOD LEVEL; URINARY EXCRETION; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; ROC CURVE;

EID: 79956331881     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.015     Document Type: Article

References (36)

1. Molitch M.E., DeFronzo R.A., Franz M.J., et al. Nephropathy in diabetes. Diabetes Care 2004, 27:S79-S83.
2. Remuzzi G., Schieppati A., Ruggenenti P. Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med 2002, 346:1145-1151.
3. Gnudi L., Thomas S.M., Viberti G. Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism. J Am Soc Nephrol 2007, 18:2226-2232.
4. An J.H., Cho Y.M., Yu H.G., et al. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. J Korean Med Sci 2009, 24:S75-S81.
5. Matheson A., Willcox M.D., Flanagan J., Walsh B.J. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 2010, 26:150-171.
6. Narita T., Hosoba M., Kakei M., Ito S. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care 2006, 29:142-144.
7. Eknoyan G., Hostetter T., Bakris G.L., et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003, 42:617-622.
8. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
9. American Diabetes Association Nephropathy in diabetes. Diabetes Care 2004, 27:S79-S83.
10. American Diabetes Association Standards of medical care in diabetes - 2010. Diabetes Care 2010, 33:S11-S61.
11. Magri C.J., Fava S. The role of tubular injury in diabetic nephropathy. Eur J Int Med 2009, 20:551-555.
12. Singh D.K., Winocour P., Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Rev Nephrol 2008, 4:216-226.
13. Barratt J., Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. Can Med Assoc J 2007, 177:361-368.
14. Hong C.Y., Chia K.S. Markers of diabetic nephropathy. J Diabetes Complications 1998, 12:43-60.
15. Herget-Rosenthal S., Poppen D., Hüsing J., et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004, 50:552-558.
16. Bagashaw S.M., Langenberg C., Haase M., Wan L., May C.N., Bellomo R. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007, 33:1285-1296.
17. Yaqoob M., McClelland P., Patrick A.W., Stevenson A., Mason H., Bell G.M. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy. Ren Fail 1995, 17:43-49.
18. Gross J.L., Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176.
19. Newman D.J., Pugia M.J., Lott J.A., Wallace J.F., Hiar A. Urinary protein and albumin excretion corrected by creatinine and specific gravity. Clin Chim Acta 2000, 294:139-155.
20. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
21. Westhuyzen J., Endre Z.H., Reece G., Reith D.M., Saltissi D., Morgan T.J. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003, 18:543-551.
22. Jung K., Pergande M., Schimice E., Ratzmann K.P., Illus A. Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy. Clin Chem 1988, 34:544-547.
23. Mohammadi-Karakani A., Asgharzadeh-Haghighi S., Ghazi-Khansari M., Hosseini M. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 2007, 21:413-417.
24. Scherberich J.E. Urinary proteins of tubular origin: basic immunological and clinical aspects. Am J Nephrol 1990, 10(Suppl 1):43-51.
25. Chew S.L., Lins R.L., Daelmans R., Nuyts G.D., De Broe M.E. Urinary enzymes in acute renal failure. Nephrol Dial Transplant 1993, 8:507-511.
26. Hartmann H.G., Braedel H.E., Jutzler G.A. Detection of renal tubular lesions after abdominal aortography and selective renal arteriography by quantitative measurements of brush-border enzymes in the urine. Nephron 1985, 39:95-101.
27. Price R.G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982, 23:99-134.
28. Melo D.A.S., Saciura V.C., Poloni J.A.T., et al. Evaluation of renal enzymuria and cellular excretion as a marker of acute nephrotoxicity due to an overdose of paracetamol in Wistar rats. Clin Chim ACta 2006, 373:88-91.
29. Kern E.F., Erhard P., Sun W., Genuth S., Weiss M.F. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis 2010, 55:824-834.
30. Russo L.M., Sandoval R.M., Campos S.B., Molitoris B.A., Comper W.D., Brown D. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol 2009, 20:489-494.
31. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
32. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in diabetes. N Engl J Med 2008, 359:1577-1689.
33. Satchell S.C., Tooke J.E. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?. Diabetologia 2008, 51:714-725.
34. Abrass C.K. Diabetic proteinuria: glomerular or tubular origin?. Am J Nephrol 1984, 4:337-346.
35. Morita E., Kaizu K., Uriu K., Hashimoto O., Komine N., Eto S. Clinical significance of urinary enzymes in diabetic nephropathy. J Diabet Complications 1991, 5:158-159.
36. Pinter G.G., Atkins J.L. What causes diabetic renal failure?. Lancet 1990, 335:590-591.